mtraore – Page 16

06/04/2016 : Launch of a new fully automated diagnostics system

Post author:mtraore
Post published:6 April 2016
Post category:Press Releases

Acceleration in the development of Theradiag’s In Vitro Diagnostics Business Unit with the development of the BioCLIA® 1 200Croissy-Beaubourg and Montpellier, April 6, 2016 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro…

22/03/2016 : Biotherapy monitoring, a major area of interest at the European Crohn’s and Colitis Organisation (ECCO) Congress

Post author:mtraore
Post published:22 March 2016
Post category:Press Releases

Presentations of the results obtained with Lisa Tracker®Croissy-Beaubourg and Montpellier, March 22, 2016 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, is announcing that the Eleventh ECCO (European…

15/03/2016 : Theradiag presents at JFHOD the results of a microRNA signature predicting a patient’s therapeutic response in locally advanced rectal cancer

Post author:mtraore
Post published:15 March 2016
Post category:Press Releases

Identification conducted as part of the miCRA project, in conjunction with the Regional Cancer Institute of Montpellier (ICM)Results presented at the JFHOD (Francophone Gastroenterology, Liver-Disease and Digestive Cancer) congress Croissy-Beaubourg and Montpellier, March 15, 2016…